change in Muscle volume In patients with LivEr cirrhosis: prospective cohort Study
- Conditions
- iver cirrhosis
- Registration Number
- JPRN-UMIN000023256
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Not provided
1.Patients being treated with intravenous albumin preparation 2.Patients being treated with fresh frozen plasma formulation 3.Patients with stage II or more advanced HCC 4.Patients with uncontrollable HCC 5.Patients with total bilirubin >3.0 mg/dl 6.Patients with hepatic encephalopathy (hepatic coma: grade III or more) 7.Patients with congenital branched-chain amino acid related metabolic disorders 8.Patients with malignancies other than HCC 9.Patients ineligible for study as determined by research investigator or research doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.